Grant: Idea to Innovation
University of Toronto
$125,000.00
A novel system for non-invasive selection of single spermatozoa with high DNA integrity for clinical in vitro fertilization (IVF) - Phase 1 I2I application
EF 2018-19
Résumé
One in six couples struggles with infertility worldwide. Intracytoplasmic sperm injection (ICSI), a procedure widely used to treat infertile couples, is a technique in which a single sperm is selected and injected into an egg with a tiny sharpened glass tube. The presence of sperm DNA damage or fragmentation in the single sperm used for ICSI lowers the fertilization rates and increases miscarriages. How do we choose the sperm with the best DNA integrity for ICSI? If we perform a standard test to assess the DNA integrity, presently, the sperm has to be destroyed in the process and cannot be used for ICSI. Since the invention of ICSI in 1992, single sperm selection for ICSI has been made by embryologists using empirical microscopic observation of single sperms' motility and morphology, which involves significant subjectivity and inconsistency. Currently, there is no technique capable of non-invasively quantifying both motility and morphology of individual sperms, or to correlate these measures with DNA integrity.*This project aims to develop the first quantitative technology for the non-invasive selection of single sperms with high DNA integrity. We are developing new computer vision microscopy and automation techniques to comprehensively measure motility and morphology parameters of single live sperms. These precisely measured characteristics of individual sperm will then be correlated to the same sperm's DNA fragmentation. The data will be used to establish machine learning models using the individual sperm motility and morphology characteristics to predict its DNA integrity. This new technology will eliminate the current subjectivity and inconsistency of sperm selection for ICSI, and standardize the selection of a single sperm with high DNA integrity to ultimately improve pregnancy rates and the health of offspring for patients undergoing IVF treatment.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
531922-2018
Name nom
Sun, Yu
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2604
Research subject group en
Robotics
Research subject group fr
Robotique
Research subject en
Intelligent systems applications
Research subject fr
Applications de systèmes intelligents
Partie
1
Nb partie
1
Application title
A novel system for non-invasive selection of single spermatozoa with high DNA integrity for clinical in vitro fertilization (IVF) - Phase 1 I2I application
Keyword
NSERC
Application summary
One in six couples struggles with infertility worldwide. Intracytoplasmic sperm injection (ICSI), a procedure widely used to treat infertile couples, is a technique in which a single sperm is selected and injected into an egg with a tiny sharpened glass tube. The presence of sperm DNA damage or fragmentation in the single sperm used for ICSI lowers the fertilization rates and increases miscarriages. How do we choose the sperm with the best DNA integrity for ICSI? If we perform a standard test to assess the DNA integrity, presently, the sperm has to be destroyed in the process and cannot be used for ICSI. Since the invention of ICSI in 1992, single sperm selection for ICSI has been made by embryologists using empirical microscopic observation of single sperms' motility and morphology, which involves significant subjectivity and inconsistency. Currently, there is no technique capable of non-invasively quantifying both motility and morphology of individual sperms, or to correlate these measures with DNA integrity.*This project aims to develop the first quantitative technology for the non-invasive selection of single sperms with high DNA integrity. We are developing new computer vision microscopy and automation techniques to comprehensively measure motility and morphology parameters of single live sperms. These precisely measured characteristics of individual sperm will then be correlated to the same sperm's DNA fragmentation. The data will be used to establish machine learning models using the individual sperm motility and morphology characteristics to predict its DNA integrity. This new technology will eliminate the current subjectivity and inconsistency of sperm selection for ICSI, and standardize the selection of a single sperm with high DNA integrity to ultimately improve pregnancy rates and the health of offspring for patients undergoing IVF treatment.